Pinned Tweet
I am excited to share the latest paper from my lab where we leverage the selection bias of condensate-promoting oncofusions to uncover molecular rules governing condensate specificity and function. cell.com/cell/fulltext/S0092….
Ben Sabari retweeted
cell.com/molecular-cell/full…
A pretty clean case study showing phase transition driven transcription regulation from @bsabari lab at UTSW
I am excited to share my lab's latest work online today @MolecularCell where we investigate the relationship between condensate formation and transcriptional activity of the cell-type specific coactivator MYOCD. cell.com/molecular-cell/full…
More broadly, our findings suggest that condensate formation can convert gradual changes in concentration (or other parameters impacting condensate formation) into sharp changes in gene expression.
Huge congratulations to first author @mikayla_eppert and all our collaborators!
1
2
117
special thanks to @shrinivaslab for elegant computational models and thoughtful discussions during the revision process.
1
1
119
Ben Sabari retweeted
New research from Fred Hutch's Steven Henikoff and @seattlechildren's Jay Sarthy suggests that rethinking cancer's origins could unlock a new generation of treatments that are both more effective and less toxic for patients. bit.ly/3UOgAIL
Ben Sabari retweeted
>be cell biology postdoc at UCLA, 1986
>job: purify vesicles from rat liver
>ez
>purify the vesicles
>something else in the tube
>weird little barrels, way bigger than a ribosome
>fkisdis
>purify the barrels instead
>mostly protein, tiny bit of RNA
>not related to vesicles at all
>new organelle just dropped?
>lab holds a naming contest
>"vaults" "sure, "great name" "
>write it up, publish
>conclusion section: "function: unknown"
>surely we'll figure it out in a couple years
>reviewers: "are you sure this isn't just a virus"
>prove it isn't a virus
>apply for grants to study it
>first question on every call: "what does it do"
>"we're working on it"
>be early 90s
>vaults hang around the nucleus
>"they must plug the nuclear pores"
>they do not
>be different scientist, Netherlands, 1995
>chasing LRP, mystery protein that shows up in chemo-resistant tumors
>clone it
>~88% identical to rat vault protein
>it was vaults the whole time
>whole cancer field piles on
>a decade of papers on vaults and drug resistance
>nobody ever proves vaults cause it
>back at UCLA
>one of the vault proteins binds telomerase
>"guys what if this is the fountain of youth"
>knock it out in mice
>telomeres fine, aging fine, mice fine
>2002
>knock out the main vault protein
>mice: perfectly healthy
>knock out all three vault proteins
>completely vaultless mice
>mice: basically fine, some subtle immune stuff
>mfw something in every cell since the dawn of eukaryotes does nothing obvious
>"just test it in yeast"
>yeast don't have vaults
>"worms then"
>no vaults
>"fruit flies"
>no vaults
>mfw every easy model organism dropped them
>try making recombinant vaults in insect cells
>expecting to get some loose protein at best
>get fully assembled vaults
>can't find a single free copy of the protein anywhere
>turns out ribosomes 3D-print the barrel straight off the mRNA
>lolwut
>still no function
>be structural biologists
>spend years modeling it as 96 proteins with 8-fold symmetry
>2009 X-ray structure
>it's 78 proteins, 39-fold
>caps still blurry
>2025: caps are closed, 13-fold, tiny hole in the middle
>still no function
>NIH funds vault research for 15 years
>NIH: "so what does it do"
>"...we're working on it"
>NIH stops returning calls
>if we can't figure out what it does, we'll make it do something
>stuff a cancer-fighting chemokine inside the barrel
>inject into mouse lung tumors
>immune cells swarm in, tumors shrink
>2011: "human trials within three years"
>2024: "human trials next year"
>2025 database: preclinical
>start a YouTube channel explaining vaults to anyone who'll listen
>be different scientist, Broad Institute
>want to record what genes a cell turned on over time
>try tethering mRNA to a bacterial protein
>doesn't work
>stumble onto a YouTube channel about some obscure barrel organelle
>engineer vaults to grab mRNA
>RNA half-life goes from ~17 hours to ~132 hours
>publish in Science, 2026
>use it to catch drug-resistance genes in lung cancer cells before the drug even hits
>the vault guy is thrilled
>still nobody knows what vaults are for
>be epigeneticists
>screen the whole genome for methylation set at random in the early embryo
>separately study kids conceived in different seasons in rural Gambia
>both screens independently point at the same gene
>it's the goddam vault RNA gene
>its methylation depends on conditions around conception, locked in for life
>linked to cancer outcomes, blood sugar, cleft palate
>mfw the mystery barrel has a mystery RNA that remembers when you were conceived
>40 years later
>one of the most abundant structures in your cells
>still not in a single textbook cell diagram
>we use it anyway because yolo
>function: unknown
>be CNRS scientist in montpellier
>dig through institut curie's chemical library looking for an HIV cure
>find a quinoline that blocks rev from exporting viral RNA
>somehow involved in splicing
>start a company called splicos based on this
>4 years later, company gets merged into abivax
>molecule is now ABX464
>run two phase 2a HIV trials
>it shrinks the viral reservoir a bit
>mfw "a bit" does not cure HIV
>but the bloodwork is weird
>random microRNA miR-124 is cranked tf up
>mfw miR-124 is a major chill pill for inflammation
>turns out the drug grabs the cap-binding complex and splices exactly one random lncRNA
>that lncRNA becomes miR-124
>why that one? lol idk
>HIV attacks GI tract, so maybe give it to colitic mice?
>guts heal lmao
>let's yolo this for ulcerative colitis
>2018 phase 2a works
>let's try with rheumatoid arthritis while we're at this
>2020 covid hits
>"what if it stops cytokine storms"
>yeah let's cure ARDS too lol
>french gov makes it a national research priority
>500 patients in
>2021 trial stopped, does nothing
>stock eats dirt
>ceo: "covid was hyper-acute, chronic inflammation is different, trust me"
>quietly drop rheumatoid arthritis
>go all in on UC
>phase 2b works
>2025 phase 3 induction hits
>stock goes vertical
>2026 maintenance trial: half get remission on drug vs 10 % on placebo
>placebo rate is the lowest ever seen in a trial like this
>NDA to FDA planned late 2026
>mfw a failed HIV drug, a failed covid drug, and a lucky lncRNA might become a blockbuster UC pill
>mfw it took 18 years
Ben Sabari retweeted
Thrilled to share my freshly "baked" Baker lab paper. We took a bottom-up approach to designing transcriptional regulators. Instead of relying on natural activation domains, we designed compact proteins that recruit specific cofactors. Activators for now, repressors to come!
Ben Sabari retweeted
That’s a wrap on our @ForbeckForums on Nuclear Condensates in Cancer! Amazing group, fantastic science, and thought-provoking discussions in beautiful Pacific Grove! A great pleasure co-organizing this with @bsabari. Many thanks to @ForbeckForums for making this possible!
Ben Sabari retweeted
Are weak TF motifs important? @ZeitlingerLab use deep learning to systematically map low-affinity pioneer binding sites in mESCs and show that they cooperate with strong motifs to open chromatin. Preview w/ @gracecbower: cell.com/cell-genomics/fullt… Paper: cell.com/cell-genomics/fullt…
Ben Sabari retweeted
i'm happy to share that our lab has joined @FoxChaseCancer! v proud of what our team achieved in Madison & now we look forward to this next chapter in the vibrant Philly scientific ecosystem - actively recruiting at all levels across the biological sciences and engineering!















